Global CAR T-Cell Therapy Market Research Report 2023

Global CAR T-Cell Therapy Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CD19 - Targeted
1.2.3 BCMA - Targeted
1.3 Market by Application
1.3.1 Global CAR T-Cell Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR T-Cell Therapy Market Perspective (2018-2029)
2.2 CAR T-Cell Therapy Growth Trends by Region
2.2.1 Global CAR T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2018-2023)
2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2024-2029)
2.3 CAR T-Cell Therapy Market Dynamics
2.3.1 CAR T-Cell Therapy Industry Trends
2.3.2 CAR T-Cell Therapy Market Drivers
2.3.3 CAR T-Cell Therapy Market Challenges
2.3.4 CAR T-Cell Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR T-Cell Therapy Players by Revenue
3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2018-2023)
3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2018-2023)
3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
3.4 Global CAR T-Cell Therapy Market Concentration Ratio
3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR T-Cell Therapy Revenue in 2022
3.5 CAR T-Cell Therapy Key Players Head office and Area Served
3.6 Key Players CAR T-Cell Therapy Product Solution and Service
3.7 Date of Enter into CAR T-Cell Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR T-Cell Therapy Breakdown Data by Type
4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2018-2023)
4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2024-2029)
5 CAR T-Cell Therapy Breakdown Data by Application
5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2018-2023)
5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America CAR T-Cell Therapy Market Size (2018-2029)
6.2 North America CAR T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America CAR T-Cell Therapy Market Size by Country (2018-2023)
6.4 North America CAR T-Cell Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR T-Cell Therapy Market Size (2018-2029)
7.2 Europe CAR T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe CAR T-Cell Therapy Market Size by Country (2018-2023)
7.4 Europe CAR T-Cell Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR T-Cell Therapy Market Size (2018-2029)
8.2 Asia-Pacific CAR T-Cell Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR T-Cell Therapy Market Size (2018-2029)
9.2 Latin America CAR T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America CAR T-Cell Therapy Market Size by Country (2018-2023)
9.4 Latin America CAR T-Cell Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR T-Cell Therapy Market Size (2018-2029)
10.2 Middle East & Africa CAR T-Cell Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis CAR T-Cell Therapy Introduction
11.1.4 Novartis Revenue in CAR T-Cell Therapy Business (2018-2023)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences CAR T-Cell Therapy Introduction
11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Business (2018-2023)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Introduction
11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2018-2023)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J CAR T-Cell Therapy Introduction
11.4.4 J & J Revenue in CAR T-Cell Therapy Business (2018-2023)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics CAR T-Cell Therapy Introduction
11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Business (2018-2023)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite CAR T-Cell Therapy Introduction
11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Business (2018-2023)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 Autolus Therapeutics(Pipeline)
11.8.1 Autolus Therapeutics(Pipeline) Company Detail
11.8.2 Autolus Therapeutics(Pipeline) Business Overview
11.8.3 Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Introduction
11.8.4 Autolus Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.8.5 Autolus Therapeutics(Pipeline) Recent Development
11.9 Sorrento Therapeutics(Pipeline)
11.9.1 Sorrento Therapeutics(Pipeline) Company Detail
11.9.2 Sorrento Therapeutics(Pipeline) Business Overview
11.9.3 Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Introduction
11.9.4 Sorrento Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.9.5 Sorrento Therapeutics(Pipeline) Recent Development
11.10 Mustang Bio(Pipeline)
11.10.1 Mustang Bio(Pipeline) Company Detail
11.10.2 Mustang Bio(Pipeline) Business Overview
11.10.3 Mustang Bio(Pipeline) CAR T-Cell Therapy Introduction
11.10.4 Mustang Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.10.5 Mustang Bio(Pipeline) Recent Development
11.11 Bluebird Bio(Pipeline)
11.11.1 Bluebird Bio(Pipeline) Company Detail
11.11.2 Bluebird Bio(Pipeline) Business Overview
11.11.3 Bluebird Bio(Pipeline) CAR T-Cell Therapy Introduction
11.11.4 Bluebird Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.11.5 Bluebird Bio(Pipeline) Recent Development
11.12 Cellectis(Pipeline)
11.12.1 Cellectis(Pipeline) Company Detail
11.12.2 Cellectis(Pipeline) Business Overview
11.12.3 Cellectis(Pipeline) CAR T-Cell Therapy Introduction
11.12.4 Cellectis(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.12.5 Cellectis(Pipeline) Recent Development
11.13 Allogene Therapeutics(Pipeline)
11.13.1 Allogene Therapeutics(Pipeline) Company Detail
11.13.2 Allogene Therapeutics(Pipeline) Business Overview
11.13.3 Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Introduction
11.13.4 Allogene Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.13.5 Allogene Therapeutics(Pipeline) Recent Development
11.14 Celyad(Pipeline)
11.14.1 Celyad(Pipeline) Company Detail
11.14.2 Celyad(Pipeline) Business Overview
11.14.3 Celyad(Pipeline) CAR T-Cell Therapy Introduction
11.14.4 Celyad(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023)
11.14.5 Celyad(Pipeline) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CD19 - Targeted
Table 3. Key Players of BCMA - Targeted
Table 4. Global CAR T-Cell Therapy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global CAR T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global CAR T-Cell Therapy Market Share by Region (2018-2023)
Table 8. Global CAR T-Cell Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global CAR T-Cell Therapy Market Share by Region (2024-2029)
Table 10. CAR T-Cell Therapy Market Trends
Table 11. CAR T-Cell Therapy Market Drivers
Table 12. CAR T-Cell Therapy Market Challenges
Table 13. CAR T-Cell Therapy Market Restraints
Table 14. Global CAR T-Cell Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global CAR T-Cell Therapy Market Share by Players (2018-2023)
Table 16. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2022)
Table 17. Ranking of Global Top CAR T-Cell Therapy Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by CAR T-Cell Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players CAR T-Cell Therapy Product Solution and Service
Table 21. Date of Enter into CAR T-Cell Therapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global CAR T-Cell Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global CAR T-Cell Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global CAR T-Cell Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global CAR T-Cell Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global CAR T-Cell Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global CAR T-Cell Therapy Revenue Market Share by Application (2018-2023)
Table 29. Global CAR T-Cell Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global CAR T-Cell Therapy Revenue Market Share by Application (2024-2029)
Table 31. North America CAR T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe CAR T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific CAR T-Cell Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America CAR T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa CAR T-Cell Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis CAR T-Cell Therapy Product
Table 49. Novartis Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead Sciences Company Detail
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences CAR T-Cell Therapy Product
Table 54. Gilead Sciences Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb CAR T-Cell Therapy Product
Table 59. Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. J & J Company Detail
Table 62. J & J Business Overview
Table 63. J & J CAR T-Cell Therapy Product
Table 64. J & J Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 65. J & J Recent Development
Table 66. JW Therapeutics Company Detail
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics CAR T-Cell Therapy Product
Table 69. JW Therapeutics Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. FOSUNKite Company Detail
Table 72. FOSUNKite Business Overview
Table 73. FOSUNKite CAR T-Cell Therapy Product
Table 74. FOSUNKite Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 75. FOSUNKite Recent Development
Table 76. CARsgen Therapeutics (Pipeline) Company Detail
Table 77. CARsgen Therapeutics (Pipeline) Business Overview
Table 78. CARsgen Therapeutics (Pipeline) CAR T-Cell Therapy Product
Table 79. CARsgen Therapeutics (Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 80. CARsgen Therapeutics (Pipeline) Recent Development
Table 81. Autolus Therapeutics(Pipeline) Company Detail
Table 82. Autolus Therapeutics(Pipeline) Business Overview
Table 83. Autolus Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 84. Autolus Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 85. Autolus Therapeutics(Pipeline) Recent Development
Table 86. Sorrento Therapeutics(Pipeline) Company Detail
Table 87. Sorrento Therapeutics(Pipeline) Business Overview
Table 88. Sorrento Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 89. Sorrento Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 90. Sorrento Therapeutics(Pipeline) Recent Development
Table 91. Mustang Bio(Pipeline) Company Detail
Table 92. Mustang Bio(Pipeline) Business Overview
Table 93. Mustang Bio(Pipeline) CAR T-Cell Therapy Product
Table 94. Mustang Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 95. Mustang Bio(Pipeline) Recent Development
Table 96. Bluebird Bio(Pipeline) Company Detail
Table 97. Bluebird Bio(Pipeline) Business Overview
Table 98. Bluebird Bio(Pipeline) CAR T-Cell Therapy Product
Table 99. Bluebird Bio(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 100. Bluebird Bio(Pipeline) Recent Development
Table 101. Cellectis(Pipeline) Company Detail
Table 102. Cellectis(Pipeline) Business Overview
Table 103. Cellectis(Pipeline) CAR T-Cell Therapy Product
Table 104. Cellectis(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 105. Cellectis(Pipeline) Recent Development
Table 106. Allogene Therapeutics(Pipeline) Company Detail
Table 107. Allogene Therapeutics(Pipeline) Business Overview
Table 108. Allogene Therapeutics(Pipeline) CAR T-Cell Therapy Product
Table 109. Allogene Therapeutics(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 110. Allogene Therapeutics(Pipeline) Recent Development
Table 111. Celyad(Pipeline) Company Detail
Table 112. Celyad(Pipeline) Business Overview
Table 113. Celyad(Pipeline) CAR T-Cell Therapy Product
Table 114. Celyad(Pipeline) Revenue in CAR T-Cell Therapy Business (2018-2023) & (US$ Million)
Table 115. Celyad(Pipeline) Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global CAR T-Cell Therapy Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global CAR T-Cell Therapy Market Share by Type: 2022 VS 2029
Figure 3. CD19 - Targeted Features
Figure 4. BCMA - Targeted Features
Figure 5. Global CAR T-Cell Therapy Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global CAR T-Cell Therapy Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. CAR T-Cell Therapy Report Years Considered
Figure 10. Global CAR T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global CAR T-Cell Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global CAR T-Cell Therapy Market Share by Region: 2022 VS 2029
Figure 13. Global CAR T-Cell Therapy Market Share by Players in 2022
Figure 14. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by CAR T-Cell Therapy Revenue in 2022
Figure 16. North America CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 18. United States CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 22. Germany CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific CAR T-Cell Therapy Market Share by Region (2018-2029)
Figure 30. China CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 38. Mexico CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa CAR T-Cell Therapy Market Share by Country (2018-2029)
Figure 42. Turkey CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia CAR T-Cell Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 45. Gilead Sciences Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 47. J & J Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 48. JW Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 49. FOSUNKite Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 50. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 51. Autolus Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 52. Sorrento Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 53. Mustang Bio(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 54. Bluebird Bio(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 55. Cellectis(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 56. Allogene Therapeutics(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 57. Celyad(Pipeline) Revenue Growth Rate in CAR T-Cell Therapy Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs